
Sun Pharma Advanced Research wins ₹28 crore CENVAT credit refund case in CESTAT
Sun Pharma Advanced Research Company won a case for a ₹27.51 crore CENVAT credit refund on Sunday (October 4). The Mumbai tribunal dismissed the Revenue's appeal, confirming the company’s entitlement to the funds plus interest. This decision finally settled the long-standing litigation that the firm first disclosed on August 14, 2023.



